Does BUSULFAN Cause Extramedullary haemopoiesis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Extramedullary haemopoiesis have been filed in association with BUSULFAN (Busulfan). This represents 0.1% of all adverse event reports for BUSULFAN.
6
Reports of Extramedullary haemopoiesis with BUSULFAN
0.1%
of all BUSULFAN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Extramedullary haemopoiesis From BUSULFAN?
Of the 6 reports, 2 (33.3%) required hospitalization.
Is Extramedullary haemopoiesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUSULFAN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BUSULFAN Cause?
Off label use (1,402)
Product use in unapproved indication (1,387)
Mucosal inflammation (880)
Venoocclusive liver disease (765)
Febrile neutropenia (628)
Cytomegalovirus infection (620)
Drug ineffective (569)
Graft versus host disease (507)
Pyrexia (502)
Cytomegalovirus infection reactivation (481)
What Other Drugs Cause Extramedullary haemopoiesis?
LUSPATERCEPT-AAMT (20)
RUXOLITINIB (18)
FILGRASTIM (10)
LUSPATERCEPT (10)
CYCLOPHOSPHAMIDE (9)
VINCRISTINE (9)
DOXORUBICIN (8)
DEXAMETHASONE (7)
RITUXIMAB (7)
FLUDARABINE (6)
Which BUSULFAN Alternatives Have Lower Extramedullary haemopoiesis Risk?
BUSULFAN vs BUSULFEX
BUSULFAN vs BUTALBITAL
BUSULFAN vs BUTENAFINE
BUSULFAN vs BUTORPHANOL
BUSULFAN vs BUTRANS